Alihossein saberi | Male infertility | Outstanding Scientist Award

Posted on by sciencefather

Dr. Alihossein saberi | male infertility | Outstanding Scientist Award

professor| Ahwaz Jundishapour University of  Medical Sciences, Iran

Dr. Alihossein Saberi is an accomplished molecular geneticist and Associate Professor at Ahvaz Jundishapur University of Medical Sciences. With a career spanning over three decades, he has held several academic and administrative positions, including Head of the Department of Medical Genetics. He earned his PhD in Molecular Medicine from Kyoto University, Japan, following a master’s in Radiation Biology from Tarbiat Modarres University, Iran. Dr. Saberi has taught and mentored extensively in molecular biology, genetics, and radiation biology. He has authored numerous research articles and textbooks, contributing significantly to the field of molecular genetics, particularly in cancer genomics, male infertility, and genetic disorders. He remains deeply involved in collaborative international research. Dr. Saberi is known for integrating teaching, administration, and impactful research to advance medical genetics education and practice in Iran and beyond.

Profile

🎓 Education

Dr. Saberi earned his PhD in Molecular Medicine from the Graduate School of Medicine at Kyoto University, Japan, between 2004 and 2007. Prior to this, he underwent a research traineeship at the same institution from 2003 to 2004. He completed his Master of Science in Radiation Biology in 1992 at Tarbiat Modarres University, Tehran, Iran, where he gained strong foundational knowledge in biomedical sciences. His education trajectory reflects a continuous focus on molecular and cellular biology, particularly genetic mechanisms underlying human health and disease. His exposure to international research environments has significantly shaped his academic and professional outlook, equipping him with advanced techniques in gene expression, molecular diagnostics, and cancer genomics. These academic qualifications have been central to his role in establishing and leading educational and research initiatives in medical genetics in Iran, enhancing both curriculum development and translational research in the domain of human genetics.

🧪 Experience

Dr. Saberi began his academic career in 1992 as a lecturer at Ahvaz Jundishapur University of Medical Sciences, advancing to Assistant Professor (2007–2013), Associate Professor (since 2013), and Head of the Department of Medical Genetics (since 2014). He also served as Deputy of Educational Affairs (1998–1999) and Dean of the Paramedical Faculty (1999–2003), showcasing his administrative leadership. Over the years, he has taught various core subjects such as Molecular Biology, Medical Genetics, and Radiation Biology. His teaching spans over 30 years and is supported by a strong research portfolio and international collaborations. His leadership has led to the development of molecular genetics curricula and enhanced the university’s role in medical genetics research and diagnostics. His blend of academic, research, and administrative roles reflects a holistic contribution to the medical education and healthcare system in Iran, making him a key figure in advancing genetics education and clinical research in the region.

🏅 Awards and Honors

Dr. Alihossein Saberi’s professional excellence is recognized through his appointment as Head of the Department of Medical Genetics and his pivotal role in curriculum reform and academic leadership at Ahvaz Jundishapur University of Medical Sciences. Although specific awards are not listed, his career progression—from lecturer to associate professor and departmental head—underscores recognition of his academic contributions. His participation in international collaborations and co-authorship of high-impact publications in renowned journals such as Genetics in Medicine, Clinical Genitourinary Cancer, and International Journal of Biological Macromolecules reflects international recognition and scientific credibility. Authoring textbooks in Persian further demonstrates his commitment to knowledge dissemination in the native language. His contributions to both education and research continue to position him as a respected expert in the Iranian academic community and an influential collaborator on global genetic research projects, often cited for his work in oncology, neurogenetics, and reproductive genetics.

🔬 Research Focus

Dr. Saberi’s research focuses on molecular genetics with special emphasis on cancer biology, reproductive genetics, and genetic basis of neurodevelopmental disorders. He explores the regulatory role of microRNAs, gene polymorphisms, and novel genetic markers in disease susceptibility and progression. Recent studies include investigations on microRNA-32 in prostate cancer, FSHB polymorphisms in male infertility, and co-delivery of gene therapies in hepatocellular carcinoma. His participation in multi-institutional genomic projects has led to groundbreaking findings in INPP4A-related neurodevelopmental disorders and biallelic mutations in ZBTB11 and MED27 genes. Using bioinformatics and translational genetics approaches, he aims to bridge the gap between molecular insights and clinical applications. He also explores the genetic basis of recurrent implantation failure and precision medicine in oncology. His collaborative work with international consortia highlights his commitment to global research excellence in human genetics, positioning him as a significant contributor to personalized medicine and molecular diagnostics.

✅ Conclusion

Dr. Alihossein Saberi is a leading molecular geneticist whose work spans academia, research, and administration, with a legacy of advancing genetic medicine education and research in Iran through decades of dedicated service, innovation, and collaboration.

Publications

  • Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells

    International Journal of Radiation Biology
    2017 | Journal article
    DOI: 10.1080/09553002.2017.1242816

    EID:

    2-s2.0-84994131604

    CONTRIBUTORS: Saberi, A.; Shahbazi-Gahrouei, D.; Abbasian, M.; Fesharaki, M.; Baharlouei, A.; Arab-Bafrani, Z.

  • Impact of prolonged fraction delivery time modelling stereotactic body radiation therapy with high dose hypofractionation on the killing of cultured ACHN renal cell carcinoma cell line

    Journal of Biomedical Physics and Engineering
    2017 | Journal article
    DOI: 10.22086/jbpe.v7i3%20Sep.582

    EID:

    2-s2.0-85029830802

    CONTRIBUTORS: Khorramizadeh, M.; Saberi, A.; Tahmasebi-birgani, M.; Shokrani, P.; Amouhedari, A.

  • The first report of a 290-bp deletion in β-globin gene in the south of Iran

    Iranian Biomedical Journal
    2017 | Journal article
    DOI: 10.18869/acadpub.ibj.21.2.126

    EID:

    2-s2.0-85012202227

    CONTRIBUTORS: Hamid, M.; Nejad, L.D.; Shariati, G.; Galehdari, H.; Saberi, A.; Mohammadi-Anaei, M.

Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Posted on by sciencefather

Dr. Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Dr. Jim Jinn-Chyuan Sheu is a professor at the Institute of Biomedical Sciences, National Sun Yat-sen University, Taiwan, and an adjunct professor in several prestigious institutions. With a PhD in Life Science from National Tsing-Hua University, his academic and industrial experiences span cancer genetics, precision medicine, and biopharmaceuticals. He has held positions at Johns Hopkins Medical Institutions and Development Center for Biotechnology. His research explores molecular mechanisms underlying diseases such as cancer and endometriosis, employing genome-wide technologies to identify biomarkers and drug targets. He actively contributes to biomedical innovation, translational medicine, and mentorship. Dr. Sheu has received numerous national and international awards, including the Wu-Da-You Memorial Award and Sigma Xi membership. He is also an ambassador for the European Association for Cancer Research. As a prolific researcher and reviewer, he plays key roles in research councils and institutional review boards, helping shape scientific policy and translational biomedical advancements in Taiwan and beyond.

Profile

Education 🎓

Dr. Sheu earned his Ph.D. in Life Science from National Tsing-Hua University, Taiwan, in 2002, where he focused on advanced molecular biology, gene expression regulation, and biomedical research. His doctoral training provided a strong foundation in cancer genetics and systems biology. Earlier, he completed his B.S. in Biology (now Life Science) from Fu-Jen University in 1994, building core competencies in biological sciences and cellular mechanisms. These educational milestones equipped him with theoretical knowledge and technical skills in genomics, proteomics, and cellular signaling, which are now reflected in his research on chromatin remodeling, cancer biomarkers, and therapeutic targets. Through rigorous academic mentorship, Dr. Sheu gained early exposure to multidisciplinary research and critical analysis, fostering his interest in precision medicine. His academic background laid the groundwork for his contributions to biomedical research, drug development, and translational science. These formative years in Taiwan’s top universities underpin his long-standing excellence in scientific discovery and innovation.

Experience 👨‍🏫

Dr. Sheu’s professional experience includes faculty roles and research leadership across academia and industry. He has served as a Professor at National Sun Yat-sen University since 2014 and previously held faculty roles at China Medical University. Internationally, he was a Research Fellow at Johns Hopkins Medical Institutions (2004–2006). Between 2003–2004, he worked in various leadership positions at the Development Center for Biotechnology, including Director of Protein Drugs Division and Project Leader. His postdoctoral and early research roles included work with Dr. Tse-Wen Chang and Dr. Carmay Lim at Academia Sinica. His academic leadership includes roles such as Associate VP of R&D, Chair of the Institute of Biomedical Sciences, and Director of Research Resources at NSYSU. He has reviewed research proposals for numerous hospitals and institutions, served on IRBs, and guided government research policy. His diverse experience bridges basic science, translational research, and biomedical entrepreneurship with national and global impact.

Awards & Recognitions 🏅

Dr. Sheu has received over 30 prestigious awards. In 2023 alone, he earned the Tien-Te Lee Award, NSYSU Outstanding Faculty Award, and top honors at the 37th Joint Biomedical Conference. He previously received the Prof. Chii-Ruey Tzeng Award, Sigma Xi membership (2021), and EACR Ambassador role (2020). His innovation was recognized by Future Tech Award and the 2020 Smart Life Innovation Competition. His studies were featured as Taiwan Research Highlights and F1000Prime recommendations. He was the 2014 recipient of the Wu-Da-You Memorial Award and the IBC Outstanding Scientific Achievement Award. He received the Medical Young Investigator Award in 2009 and the Best Basic Science Award at Johns Hopkins in 2005. As a government-financed scholar to the U.S., his academic excellence has been internationally recognized. He consistently ranks among Taiwan’s top biomedical researchers, illustrating his impact through award-winning research in endometriosis, cancer stemness, diagnostics, and therapeutic innovation.

Research Interests 🔬

Dr. Sheu’s research focuses on cancer genetics and genomics, endometriosis, precision medicine, chromatin remodeling, cytoskeletal dynamics, cell adhesion and invasion, and mechanotransduction. His lab investigates how abnormalities in gene expression and chromatin structure drive disease progression, especially in gynecologic cancers and endometriosis. By applying genome-wide analysis and bioinformatics, his team identifies disease-driving genes and develops novel diagnostic tools and therapeutic strategies. A key interest is the tumor microenvironment and how cytoskeletal networks and nuclear architecture influence cancer stemness and metastasis. His group explores traditional Chinese medicine compounds and stem cell therapies, advancing integrative approaches to medicine. Antibody and vaccine engineering are also integral to his translational pipeline. Funded by NSTC Taiwan and other institutions, his projects target non-invasive diagnostics and biomarker-based interventions. His long-term vision involves bridging molecular biology, clinical application, and therapeutic innovation to impact patient care and global health through interdisciplinary and precision-driven biomedical science.

Publications

Ali Osman | Life Science | Best Researcher Award

Posted on by sciencefather

Dr. Ali Osman | Life Science | Best Researcher Award

👨‍🔬 Prof. Ali Osman Mohamed Osman Khalil is a distinguished biochemist specializing in agricultural sciences. 🎓 He earned his PhD in Biochemistry from Zagazig University, Egypt, in 2012. 🏫 Currently, he serves as a Professor at the Biochemistry Department, Faculty of Agriculture, Zagazig University. 📚 With over 130 international publications and an impressive h-index of 33 (Google Scholar), his research has significantly impacted agricultural biochemistry. 🏅 He has received prestigious awards, including the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and First Class Scientific Franchise from the President (2017). 🌱 His research focuses on environmentally friendly bioproducts, plant disease control, and biochemical applications in agriculture. 🌍 He is an active member of international scientific societies and serves as an external reviewer for renowned journals. ✨ Prof. Khalil has also collaborated on major scientific projects, contributing to advancements in biochemistry and sustainable agriculture.

Profile

Education 🎓

📜 Prof. Khalil holds a PhD in Biochemistry (2012) from Zagazig University, Egypt, with excellence. 🏆 His academic journey started with a B.Sc. in Agricultural Sciences-Biochemistry (2004), followed by an M.Sc. in Biochemistry (2008), both earned with distinction. 🎯 His studies focused on the biochemical mechanisms in agriculture, leading to his expertise in plant sterols, post-harvest protection, and biochemical applications in food science. 🔬 He has undertaken international fellowships, including INRA-France (2007-2008) and Umeå University-Sweden (2023-2024), enriching his research in clinical microbiology, infection, and immunology. 🌍 His educational background has provided a strong foundation for his pioneering research in agricultural biochemistry and food technology.

Experience 👨‍🏫

🔬 Prof. Khalil has over 20 years of academic experience at Zagazig University, Egypt. 📚 He began as a Teaching Assistant (2004-2008), then progressed to Assistant Lecturer (2008-2012) and Lecturer (2012-2017). 🎓 His expertise led to his promotion as an Assistant Professor (2017-2022) and later Professor (2022-present) in Biochemistry. 🏛️ His teaching covers biochemical applications in agriculture, plant metabolism, and molecular biochemistry. 🏅 He has supervised numerous postgraduate students, fostering the next generation of scientists. 🔍 As a principal investigator and collaborator in several international projects, he has worked on plant disease control, bioproduct development, and oxidation mechanisms. 📑 His editorial contributions include reviewing for top journals like LWT-Food Science and Technology, International Dairy Journal, and the African Journal of Agricultural Research. 🌍 His extensive research and teaching experience have solidified his reputation as a leading expert in biochemistry.

Awards & Recognitions 🏅

🎖️ Prof. Khalil has received numerous awards for his outstanding contributions to biochemistry and agricultural sciences. 🏅 In 2017, he was honored with the First Class Scientific Franchise by the Egyptian President for his scientific achievements. 🏆 He won the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and the Zagazig University Prize for Encouragement in Agricultural Sciences (2017). 🍏 His research excellence was recognized with the George Steno Award for Best Applied Research in Pomology (2017). 🌍 His global impact in plant biochemistry is further demonstrated by his international fellowships at INRA-France (2007-2008) and Umeå University-Sweden (2023-2024). 💡 As a member of esteemed scientific societies, including the American Chemical Society and Egyptian Botanical Society, he actively contributes to advancing agricultural research. 📚 His accolades reflect his dedication to innovation, sustainability, and scientific excellence in biochemistry

Research Interests 🔬

🌿 Prof. Khalil’s research primarily revolves around biochemical applications in agriculture, including post-harvest disease control, plant metabolism, and sustainable bioproducts. 🧪 His h-index of 33 (Google Scholar) and 132 SCOPUS-indexed publications highlight his impactful work. 🔍 As the Principal Investigator of projects like “Fighting Plant Fungi Post-Harvest Using Environmentally Friendly Bioproducts”, he explores innovative solutions for agricultural sustainability. 🌱 His research extends to plant sterol oxidation, polymerization, and antiviral strategies for plant protection. 📊 His expertise in biochemical pathways and molecular interactions has led to the development of novel biochemical strategies to enhance crop productivity and food safety. 🌍 His international collaborations, including a Spanish-Egyptian research project on molecular modeling, further advance his contributions to biochemistry, plant pathology, and environmental sustainability. ✨ His work bridges biochemistry and agriculture, making significant strides toward sustainable farming solutions

4Publications 

1. Eskandrani, A. A., Alsubaie, N., Bawahab, A. A., Abd-Elhakim, Y. M., Ibrahim, R. E.,
Khamis, T., Osman, A,… & Mohamed, A. A. R. (2025). Whey protein hydrolysate from
camel mitigates hypoxia-induced renal and gill damage in Nile Tilapia: Effects on stress, HIFα, apoptosis, inflammation, and metabolic pathways. Aquaculture, 742256.
2. Alsubaie, N., Mohamed, A. A. R., Metwally, M. M., Khamis, T., Osman, A., Alotaibi, B. S.,
… & Ibrahim, R. E. (2025). Alkalinity exposure induced growth inhibition, intestinal
histopathological changes, and down-regulated nutrient transporter expression in Nile Tilapia:
The ameliorative role of dietary camel whey protein hydrolysates. Comparative Biochemistry
and Physiology Part B: Biochemistry and Molecular Biology, 111074.
3. Alsubaie, N., Ibrahim, R. E., Bawahab, A. A., Mohamed, A. A. R., Abd-Elhakim, Y. M.,
Khamis, T., Osman, A., … & Ghannam, H. E. (2025). Ameliorative role of camel protein
hydrolysates diet against alkaline stress in Oreochrmis niloticus: Hematology, immune
responses and their regulating genes expression, and histopathological assays. Veterinary
Research Communications, 49(2), 79.
4. Dahran, N., Alotaibi, B. S., Abd-Elhakim, Y. M., Ibrahim, R. E., Metwally, M. M., Khamis,
T.,El-Far, A., Osman, A., … & Mohamed, A. A. R. (2025). Effects of camel whey protein
hydrolysate on growth, nutrient metabolism, and tight junction protein gene expression in
Oreochromis niloticus under hypoxia stress. Aquaculture International, 33(2), 137.
5. Elsheikh, M., Osman, A., Edris, S., Dawam, W., Sitohy, M., & Sabeq, I. (2024). Soybean
Glycinin’s Antibacterial Properties Provide a Feasible Natural Alternative for Improving the
Overall Quality and Shelf-Life of Beef Steaks and Combating Foodborne Pathogens. Food
and Bioprocess Technology, 1-16.
6. Amer, S. A., Ibrahim, R. E., Younis, E. M., Abdel-Warith, A. W. A., Osman, A., Davies, S.
J., & Shakweer, M. S. (2025). Potential of using kidney bean (Phaseolus vulgaris L) protein
hydrolysate as a plant protein supplement in Nile tilapia (Oreochromis niloticus) diets: effects
on growth, hematology, histology, and blood biochemical parameters. Aquaculture
International, 33(1), 95.
7. Amer, S. A., Behairy, A., Moustafa, A. A., Eltanahy, A., Younis, E. M., Abdel-Warith, A. W.
A., Osman, A., … & Tolba, S. A. (2024). Effects of dietary Arthrospira platensis phycocyanin
on growth, fatty acid assessment of breast muscles, hematobiochemical, immunological
responses, and hepatic histomorphology in broiler chickens. Journal of Applied
Phycology, 36(6), 3367-3380.
8. Ibrahim, R. E., Elshopakey, G. E., Aly, M. Y., Abdelwarith, A. A., Younis, E. M., AbdElhakim, Y. M., Khamis, T., Osman, A., … & Mohamed, A. A. R. (2024). Camel whey
protein hydrolysate diet mitigates alkaline stress–induced biochemical disorders and restores
the target of rapamycin, MAPK pathway, and autophagy-related gene expression in Nile
tilapia. Aquaculture International, 32(7), 9911-9932.
9. Sitohy, M., Enan, G., Abdel-Shafi, S., El-Wafa, N. A., El-Gazzar, N., Osman, A., & Sitohy,
B. (2024). Mapping pathogenic bacteria resistance against common antibiotics and their
potential susceptibility to methylated white kidney bean protein. BMC microbiology, 24(1),
49.
10. Amer, S. A., Rahman, A. N. A., ElHady, M., Osman, A., Younis, E. M., Abdel-Warith, A.
W. A., … & Ibrahim, R. E. (2024). Use of moringa protein hydrolysate as a fishmeal replacer
in diet of Oreochromis niloticus: effects on growth, digestive enzymes, protein transporters
and immune status. Aquaculture, 579, 740202.
11. Imbabi, T. A., El‐Sayed, A. I., Radwan, A. A., Osman, A., & Abdel‐Samad, A. M. (2024).
Prevention of aflatoxin B1 toxicity by pomegranate peel extract and its effects on growth,
blood biochemical changes, oxidative stress and histopathological alterations. Journal of
Animal Physiology and Animal Nutrition, 108(1), 174-184.

Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Posted on by sciencefather

Prof Dr. Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur Müdüroğlu Kırmızıbekmez is a neuroscientist at İstanbul Nişantaşı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinson’s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TÜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education 🎓

Aynur Müdüroğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimer’s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynur’s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience 👨‍🏫

With over a decade of experience, Aynur Müdüroğlu Kırmızıbekmez has been an Assistant Professor at İstanbul Nişantaşı University since 2014. She has led multiple national and international neuroscience projects, including TÜSEB-approved research on Parkinson’s and Alzheimer’s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests 🔬

Aynur Müdüroğlu Kırmızıbekmez’s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimer’s, Parkinson’s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynur’s projects also include SNP-based qPCR diagnostic tools for Alzheimer’s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions 🏅

Aynur Müdüroğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TÜSEB for her groundbreaking research in stem cell therapy for Parkinson’s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TÜBİTAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications 📚

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Başpınar Küçük H, Zaim M, Şentürk AM, Müdüroğlu Kırmızıbekmez
    A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erözden AA, Tavşanlı N, Müdüroğlu A, Çalışkan M, Kara İ. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, Müdüroğlu Kirmizibekmez Aynur, Altunel Emine Özlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)

PhongSon Dinh | Gene function analysis | Best Researcher Award

Posted on by sciencefather

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. 🧬🔬

Profile

Education 🎓

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. 🎓📚

Experience 👨‍🏫

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. 🔬💡

Research Interests 🔬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. 🔬🧬

Awards & Recognitions 🏅

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. 🏆🏅

Publications 📚

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 | Journal article
    DOI: 10.1016/j.bbrep.2025.101952
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Hai-Anh Ha; Aigul Utegenova; Awais Ali; Abdulaziz Alamri

  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 | Journal article
    DOI: 10.1080/07391102.2023.2225109
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Awais Ali; ShangLing Pan

  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 | Journal article
    DOI: 10.1080/07391102.2024.2328744
    CONTRIBUTORS: ChauMyThanh Tran; PhongSon Dinh

  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 | Journal article
    DOI: 10.3389/fcvm.2023.1104223
    Part of ISSN: 2297-055X
    CONTRIBUTORS: PhongSon Dinh; JunHua Peng; ThanhLoan Tran; DongFeng Wu; ChauMyThanh Tran; ThiPhuongHoai Dinh; ShangLing Pan

Lekshmi K. Edison | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr.Lekshmi K. Edison | Molecular Biology| Best Researcher Award

 

University of Florida, United States

Profile

Education

She earned her Ph.D. in Biotechnology from the University of Kerala, India, in 2019. Prior to that, she completed a Master’s in Biotechnology from Mahatma Gandhi University in 2006 and an undergraduate degree in Zoology from the same university in 2004. Additionally, she holds a Master’s Diploma in Bioinformatics from Bharathiyar University (2015) and a Diploma in Computer Application from C-Dit, India (2014).

Work experience

She is currently a Postdoctoral Associate at the College of Veterinary Medicine, University of Florida, Gainesville, FL, United States, a position she has held since 2022. Prior to this, she worked as a Postdoctoral Associate at the College of Medicine, University of Florida, from 2021 to 2022. From 2019 to 2021, she served as a Postdoctoral Research Associate at the Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, Kerala, India. Earlier in her career, she was a Research Fellow at KSCSTE-JNTBGRI, Palode, Kerala, from 2015 to 2019, and a Project Fellow at the Department of Plant Physiology, College of Agriculture, Vellayani, Kerala, from 2011 to 2013.

Awards

She has received several prestigious honors and awards throughout her career. In 2024, she was awarded the UF Postdoctoral Affairs Spring 2024 Travel Award by the University of Florida and the American Society of Microbiology (ASM) Future Leaders Mentorship Fellowship (FLMF). In 2023, she received the American Society of Virology Postdoctoral Scholar Travel Award. Earlier, she was honored with the Department of Biotechnology-Research Associateship Program Fellowship from the Government of India in 2019. Additionally, she received the Women Scientist’s Back to Lab Research Fellowship from the State Government of Kerala, India, in 2015, and qualified for the National Eligibility Test for Lectureship conducted by the Indian Council of Agricultural Research, Government of India, in 2014.

 OTHER PROFESSIONAL CREDENTIALS (LICENSURE, CERTIFICATION, ETC)

She has obtained multiple professional certifications and training credentials. In 2024, she completed the HiPerGator Account Training at the University of Florida, along with certifications in NIH Recombinant DNA (rDNA) and Nanoparticle Biosafety/Biosecurity through CITI. She also received training from the American Association for Laboratory Animal Science (AALAS) in areas such as working safely with rabbits and ferrets in biocontainment and working with laboratory rats. In 2023, she completed the Life Sciences Responsible Conduct of Research Course, training on COVID-19 vaccine research, and multiple AALAS certifications, including working with the IACUC and poultry in laboratories. Earlier, in 2021, she acquired certifications in laboratory animal science, pain management in research animals, and post-procedure care for mice and rats.

Book Edited

  •  Pradeep NS, Edison LK (Editors). 2022. Microbial Beta Glucanases – Molecular
    Structure, Functions and Applications. In Book Series: Interdisciplinary
    Biotechnological Advances. Springer Nature Singapore Pte Ltd., Pages 206. DOI
    https://doi.org/10.1007/978-981-19-6466-4, ISBNs 978-981-196465-7 (Hard cover),
    978-981-196466-4 (eBook).

Book chapters

  • Edison LK, Pradeep NS. Isolation of beta-glucanase encoding genes from actinobacterial
    genus Streptomyces spp. and its overexpression in Escherichia coli heterologous system. In:
    Karthik L, ed. Protocols of Actinomycetes: Microbiology to Gene Editing. 1st ed. Boca Raton,
    FL: CRC Press; 2024:Chapter 11. doi:10.1201/9781003398400-11
  • Nair S, Sahay B, Arukha AP, Edison LK, Crews CD, Morris JG Jr, Kariyawasam S,
    Yamamoto JK. Interferon-γ/IL-2 ELISpot and mRNA Responses to the SARS-CoV2, Feline
    Coronavirus Serotypes 1 (FCoV1), and FCoV2 Receptor Binding Domains by the T Cells
    from COVID-19-Vaccinated Humans and FCoV1-Infected Cats. Methods Mol Biol.
    2024;2768:135-151. doi: 10.1007/978-1-0716-3690-9_9.
  • Ragitha VM, Edison LK. Safety issues, environmental impacts, and health effects of
    Biopolymers. In: Thomas S, Ar A, Jose Chirayil C, Thomas B, eds. Handbook of Biopolymers.
    Springer; 2022. doi:10.1007/978-981-16-6603-2_54-1.

Publication